Evidence map›Paper›PMID 32379490›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Feasibility of Plasma-Methylated

Jin Miao, Yi Liu, Guodong Zhao, Xiaoyu Liu, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Shangmin Xiong, Minxue Zheng and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Novel biomarkers for early detection of gastric cancer.World journal of gastroenterology · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Long non-coding RNAThe Journal of international medical research · 2022
    Article
  15. mFrontiers in genetics · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jin MiaoDepartment of Gastroenterology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Jiangsu, China.
Yi LiuDepartment of Gastroenterology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Jiangsu, China.
Guodong ZhaoZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.ORCID https://orcid.org/0000-0001-9817-3791
Xiaoyu LiuZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.
Yong MaSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, China.
Hui LiDepartment of Gastroenterology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Jiangsu, China.
Shiming LiZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.
Yun ZhuZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.
Shangmin XiongZhejiang University Kunshan Biotechnology Laboratory, Zhejiang University Kunshan Innovation Institute, Kunshan, Jiangsu, China.
Minxue ZhengSuzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, China.
Sujuan FeiDepartment of Gastroenterology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Jiangsu, China.ORCID https://orcid.org/0000-0002-2827-536X
Duke Kunshan University · CNXuzhou Medical College · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is fifth most frequently diagnosed cancer and second leading cause of cancer in China. More than 80% of GC are diagnosed at an advanced stage due to low uptake rate of invasive screening method. The performance of methylated

Indexed as

DNA MethylationAdultAgedAged, 80 and overAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCarcinoembryonic AntigenCase-Control StudiesEarly Detection of CancerFeasibility StudiesFemaleHumansMaleMembrane ProteinsMiddle AgedROC CurveAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCA 242 antigenCA-72-4 antigencarbohydrate antigen 199, humanCarcinoembryonic AntigenMembrane ProteinsSecreted Frizzled-Related ProteinsSFRP2 protein, humanGastric cancergastric intestinal metaplasiamethylated SFRP2sensitivityspecificity

Identifiers

PMID32379490
PMCPMC7218304
OpenAlexW3022189946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.